Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial | Zendy

Lars Jakobsen | Zendy; Evald Høj Christiansen | Zendy; Phillip Freeman | Zendy; Johnny Kahlert | Zendy; Karsten Tange Veien | Zendy; Michael Mæng | Zendy; Bent Raungaard | Zendy; Julia Ellert | Zendy; Anton Boel Villadsen | Zendy; Steen Dalby Kristensen | Zendy; Ole Ahlehoff | Zendy; Martin Kirk Christensen | Zendy; Christian Juhl Terkelsen | Zendy; Hans Erik Bøtker | Zendy; Jens Aarøe | Zendy; Troels Thim | Zendy; Leif Thuesen | Zendy; Ahmed Aziz | Zendy; Ashkan Eftekhari | Zendy; Rebekka Vibjerg Jensen | Zendy; Nicolaj B. Støttrup | Zendy; Jeppe Groendal Rasmussen | Zendy; Anders Junker | Zendy; Svend Eggert Jensen | Zendy; Henrik Hansen | Zendy; Lisette Okkels Jensen | Zendy

Open Access

Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial

Author(s) -

Lars Jakobsen,

Evald Høj Christiansen,

Phillip Freeman,

Johnny Kahlert,

Karsten Tange Veien,

Michael Mæng,

Bent Raungaard,

Julia Ellert,

Anton Boel Villadsen,

Steen Dalby Kristensen,

Ole Ahlehoff,

Martin Kirk Christensen,

Christian Juhl Terkelsen,

Hans Erik Bøtker,

Jens Aarøe,

Troels Thim,

Leif Thuesen,

Ahmed Aziz,

Ashkan Eftekhari,

Rebekka Vibjerg Jensen,

Nicolaj B. Støttrup,

Jeppe Groendal Rasmussen,

Anders Junker,

Svend Eggert Jensen,

Henrik Hansen,

Lisette Okkels Jensen

Publication year - 2021

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.120.052766

Subject(s) - medicine , sirolimus , percutaneous coronary intervention , stent , randomized controlled trial , conventional pci , surgery , cardiology , myocardial infarction

Target lesion failure remains an issue with contemporary drug-eluting stents. Thus, the dual-therapy sirolimus-eluting and CD34+ antibody-coated Combo stent (DTS) was designed to further improve early healing. This study aimed to investigate whether the DTS is noninferior to the sirolimus-eluting Orsiro stent (SES) in an all-comers patient population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog